3 ms·
Mounjaro (tirzepatide) and Wegovy (semaglutide) are the new class of weight loss drugs. And their results, crush anything before them. Once the price point of
by aantix 4y ago
Mounjaro (tirzepatide) and Wegovy (semaglutide) are the new class of weight loss drugs.
And their results, crush anything before them.
Once the price point of these medications come down, you're going to see a massive movement towards these solutions for long term weight loss.
It's clear that motivation, accountability, peer pressure simply aren't enough for long term success in keeping weight off.
By long term success, I mean decades of keeping the weight off.
The abysmal dieting numbers prove this.
The Neuroscience of Obesity | Peter Attia, M.D. & Stephan Guyenet, Ph.D.
https://www.youtube.com/watch?v=9G3iLbQCIHI&t=7646s https://www.youtube.com/watch?v=9G3iLbQCIHI&t=7646s
- aantix 4y agoThere's a startup opportunity here. We saw it with generic Viagra and Hims and Roman. Calibrate is the early mover in GLP-1 medications coupled with nutritional coaching, but there's a ton of room for competitors.
- aantix 4y agoI've personally used Calibrate's platform. There's zero transparency to the medication approval process. If you ask a question, you will 1) receive an email 3-5 days later and 2) told that they generally don't provide status updates on medication. No transparency to the medication approval process, even though obtaining access to a GLP-1 medications for their patients, is a pillar of their business. Not even a simple "waiting to hear from insurance" on their dashboard. Super long delays and a snarky support staff to get basic medical questions answered. Here's their site. https://www.joincalibrate.com/ https://www.joincalibrate.com/ There's room for competitors.